Clinical Trials Directory

Trials / Completed

CompletedNCT02276859

Normal Versus Dual Wave Insulin Bolus for High-protein Food

The Optimal Type of Bolus Following a High-protein Meal in Type 1 Diabetic Children Treated With Insulin Pumps

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Medical University of Warsaw · Academic / Other
Sex
All
Age
10 Years – 18 Years
Healthy volunteers
Not accepted

Summary

Patients receive a standardized high-protein test meal at breakfast time. Insulin is given as bolus (normal or dual-wave (normal plus square) and basal rate using an insulin pump. The 3h post-meal glucose excursions will be recorded by self-blood glucose measurements (SMBG) (every 1 hour) and continuous glucose monitoring system (CGMS). The intervention is taking part under in-patient clinical conditions.

Detailed description

The dual-wave bolus delivers an immediate normal pre-meal insulin bolus followed by square-wave bolus that is evenly delivered over several hours as programmed by the patient. The aim of this study is to compare post-prandial glycaemic excursions following a high-protein meal after administration of insulin by normal vs dual-wave bolus. During this prospective, cross-over, repeated measures study, pediatric patients with type 1 diabetes, treated with insulin pump therapy will be evaluated using the self-blood glucose measurements following standardized high-protein meal and two types of boluses (normal or dual-wave). The required insulin dose will be calculated based on patient's insulin-exchange ratio. A high-protein meal will be given on two subsequent breakfasts and comparisons will be made between normal and dual-wave insulin bolus delivery. Prolonged post-prandial glycaemic excursions will be identified using the CGMS.

Conditions

Interventions

TypeNameDescription
DRUGinsulin aspartA kind of study bolus insulin will be insulin aspart if participant used insulin aspart before entering the trial
DRUGinsulin lisproA kind of study bolus insulin will be insulin lispro if participant used insulin lispro before entering the trial
DRUGinsulin glulisineA kind of study bolus insulin will be insulin glulisine if participant used insulin glulisine before entering the trial

Timeline

Start date
2014-10-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2014-10-28
Last updated
2018-01-31

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT02276859. Inclusion in this directory is not an endorsement.